SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-338711
Filing Date
2014-09-11
Accepted
2014-09-11 09:26:29
Documents
3
Period of Report
2014-09-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d787490d8k.htm 8-K 15347
2 EX-99.1 d787490dex991.htm EX-99.1 54076
3 GRAPHIC g787490g30b42.jpg GRAPHIC 14860
  Complete submission text file 0001193125-14-338711.txt   91184
Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 141097281
SIC: 2836 Biological Products, (No Diagnostic Substances)